Kawasaki disease: effect of treatment on coronary artery involvement.
about
Kawasaki syndromeKawasaki diseaseAcute Kawasaki disease: not just for kidsUse of corticosteroids during acute phase of Kawasaki diseaseKawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future researchHigh-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki DiseaseKawasaki Disease and Labyrinthitis: An Underdiagnosed Complication.Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europeClinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.Infliximab treatment for refractory kawasaki disease in korean children.Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via activating amp-activated protein kinase (AMPK) signalingKawasaki disease: Canadian update.Steroid pulse therapy for Kawasaki disease unresponsive to additional immunoglobulin therapyPlatelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and functionKawasaki disease, or mucocutaneous lymph node syndrome: report of seven cases in North America.Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008.A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease.Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease.Elevated Serum Levels of IL-21 in Kawasaki Disease.The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinasesEtanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents.Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease.Kawasaki disease at British Columbia's Children's Hospital.Management of Kawasaki disease.Two cases of super-giant coronary aneurysms after kawasaki diseaseCorticosteroid therapy for primary treatment of Kawasaki disease - weight of evidence: a meta-analysis and systematic review of the literature.Kawasaki disease: etiopathogenesis and novel treatment strategies.Dermatology-epitomes of progress: high doses of aspirin in the treatment of mucocutaneous lymph node syndromeMucocutaneous lymph node syndrome (Kawasaki disease) in an adult.The use of anticoagulation in pediatric cardiac disease.Cardiovascular involvement in Kawaski Disease.Recognizing Kawasaki disease.Screening of differentially expressed genes associated with Kawasaki disease by microarray analysis.Controversies in diagnosis and management of Kawasaki disease.Effectiveness of intravenous immunoglobulin alone and intravenous immunoglobulin combined with high-dose aspirin in the acute stage of Kawasaki disease: study protocol for a randomized controlled trial.
P2860
Q24550744-16D0996A-A77A-44D5-B0C7-518CDF3823D0Q24654153-D99AF38B-BA1E-450E-B397-76E13D583D6EQ24682484-8D295209-3D67-4478-AF46-DBE26D67BA07Q26777190-822F9A0A-3CAD-4D75-8045-EDBCAAA62579Q28192643-626DD3C6-6E36-4301-88ED-6EBE269B758BQ28396984-129F94F8-8B2B-4688-AF13-B38E06009812Q30358570-DE63B033-0777-4E2B-9699-0ADD8245A39EQ33419638-F52E61F9-EC64-4BB8-B29A-4AFFC5E41ACBQ33941598-B185513E-5BF0-4BEA-942F-C821A3D1869DQ34021198-03318178-3FF4-4790-BE96-47A205AA8545Q34072358-A776EE33-4323-4F5B-8F98-ED649A26C947Q34300599-8773BE74-B7BD-4656-9B99-14682C3386CBQ34302870-15A2E782-21C0-4D05-9EB6-DE90DB0FFF32Q34484695-03CDFB78-A204-40C3-9F35-0996A99CA126Q35375079-7DDCC813-045B-4F98-8709-8418F96F4D47Q35644928-FD215670-ADF7-4E9C-A5D0-AA7C3B829DA6Q35691096-AA2BE2AF-82EB-4102-BFD4-F00CC23866DCQ35772471-D6342309-8A17-4048-AFC7-8BA966D9190BQ36104063-1B12B6AF-A836-414D-8696-8A4338D152CFQ36341625-6E2D95D4-8FE5-43E1-94E2-4276F5C0C697Q36600699-B87182FF-089E-48A7-982D-8400DD494AB0Q36766177-671ED9FA-E5FB-458C-852B-8534A44A94E3Q36797800-3BC4CE61-C3FE-4B5A-A4BA-90BB43FDD23CQ37289341-758B15C5-AF22-44DC-9681-060840627717Q37465500-B16F6ACF-992F-4467-9BCC-039B47076CBDQ37525981-26E1885B-C7DC-4711-B81D-C2E257A67838Q37585123-9E488383-DC7B-4A37-AA93-D9FFEEB352E0Q38945126-A27FF3B4-3B0C-4179-808A-C7BC6C0B9B74Q39343045-9BE965D0-3EC4-44DB-BCE3-75EA421FF355Q39371539-3BD38BD4-9889-4753-B2A4-BBAF24760628Q39653469-9642379A-54B0-4425-8E4A-579084A7822EQ39654279-D0026291-82F2-4A2E-994F-1ACBB18AC1DCQ40593999-22932E93-CD9D-4C74-818D-CEA190F03185Q41665077-A5ECDCD3-491E-4177-962E-9F8A3329DC48Q49873428-3C3F5073-1C99-437A-9459-78E621F20A23Q55446513-F51E641F-6DD5-4B93-8FB1-9FA209ED4B8E
P2860
Kawasaki disease: effect of treatment on coronary artery involvement.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Kawasaki disease: effect of treatment on coronary artery involvement.
@en
type
label
Kawasaki disease: effect of treatment on coronary artery involvement.
@en
prefLabel
Kawasaki disease: effect of treatment on coronary artery involvement.
@en
P2093
P1433
P1476
Kawasaki disease: effect of treatment on coronary artery involvement.
@en
P2093
P304
P407
P577
1979-02-01T00:00:00Z